Literature DB >> 19578350

Risk factors: improved risk stratification for prostate cancer.

Hendrik Isbarn, Pierre I Karakiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19578350     DOI： 10.1038/nrurol.2009.106

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

1.  Pretreatment PSA velocity and risk of death from prostate cancer following external beam radiation therapy.

Authors:  Anthony V D'Amico; Andrew A Renshaw; Brenda Sussman; Ming-Hui Chen
Journal:  JAMA       Date:  2005-07-27       Impact factor: 56.272

2.  Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; James A Eastham; Fernando J Bianco; Zohar A Dotan; Paul A Fearn; Michael W Kattan
Journal:  J Natl Cancer Inst       Date:  2006-05-17       Impact factor: 13.506

3.  Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

Authors:  Anthony V D'Amico; Ming-Hui Chen; Kimberly A Roehl; William J Catalona
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

4.  External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.

Authors:  Shahrokh F Shariat; Jochen Walz; Claus G Roehrborn; Alexandre R Zlotta; Paul Perrotte; Nazareno Suardi; Fred Saad; Pierre I Karakiewicz
Journal:  J Clin Oncol       Date:  2008-03-20       Impact factor: 44.544

5.  Predicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factors.

Authors:  Paul L Nguyen; Ming-Hui Chen; William J Catalona; Judd W Moul; Leon Sun; Anthony V D'Amico
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-07       Impact factor: 7.038

6.  Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; D Schultz; K Blank; G A Broderick; J E Tomaszewski; A A Renshaw; I Kaplan; C J Beard; A Wein
Journal:  JAMA       Date:  1998-09-16       Impact factor: 56.272
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.